Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04369729 · ClinicalTrials.gov registry record
Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache
A clinical trial of Post-Traumatic Headache, sponsored by Mayo Clinic.
- Completed
- Registry status
- 101
- Enrollment target
- 5
- Study locations
NCT04369729: Completed study of Post-Traumatic Headache, sponsored by Mayo Clinic.
NCT04369729 is a study of Post-Traumatic Headache that has completed, run by Mayo Clinic. The registered enrollment target is 101 participants, below the 165-participant average among 11 other Post-Traumatic Headache trials with a reported enrollment target (39% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04369729, a study of Post-Traumatic Headache, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a United States Department of Defense funded Focused Program study that aims to identify mechanisms and predictors for persistent of post-traumatic headache attributed to mild traumatic brain injury, and identify methods of preventing post-traumatic headache persistence
Primary Outcome
descriptive analysis of post-traumatic headache characteristics such as headache frequency and severity, and characteristics of associated conditions such as symptoms of sensory hypersensitivities, anxiety, depression, insomnia, autonomic dysfunction, and cognitive function
Conditions Studied
Study Locations (5)
Arizona
- Phoenix VA Health Care System - Phoenix
- Mayo Clinic - Phoenix
- Mayo Clinic - Scottsdale
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2025-08-31 |
What the finished NCT04369729 record still lists
NCT04369729 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 165-participant average among 11 other Post-Traumatic Headache trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Post-Traumatic Headache appearing as the primary indexed condition, and to 0 interventions.
NCT04369729 lists 5 locations in 3 states (Arizona, Florida, Minnesota).
Frequently Asked Questions
What is clinical trial NCT04369729 about?
NCT04369729 is a clinical study titled "Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache". This is a United States Department of Defense funded Focused Program study that aims to identify mechanisms and predictors for persistent of post-traumatic headache attributed to mild traumatic brain injury, and identify methods of preventing post-traumatic headache persistence
What is the current status of trial NCT04369729?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2020-09-09. Estimated completion is 2025-08-31.
What conditions does trial NCT04369729 study?
This clinical trial studies the following conditions: Post-Traumatic Headache.
Who is sponsoring clinical trial NCT04369729?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04369729 being conducted?
This trial has 5 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Traumatic Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04369729's enrollment target sits among peer trials
101 7th of 11 higher than 5 of 11 other Post-Traumatic Headache trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post-Traumatic Headache trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
RECRUITING · NA
-
Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 1
RECRUITING · Phase 1
-
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
RECRUITING · Phase 2
-
Multisite Advancement of Research on Chronic Posttraumatic Headache
RECRUITING · NA
-
Ketamine, SGB and Combination Treatment for TBI
RECRUITING · Phase 2
-
e-CBT DTx for Post Traumatic Headaches in Adults With History of TBI
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI